IFP Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 4569 |
|
|
2025
Q1 | – | Sell |
-1
| Closed | -$17 | – | 4628 |
|
|
2024
Q4 | $17 | Buy |
+1
| New | +$17 | ﹤0.01% | 4477 |
|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$807 | – | 3424 |
|
|
2024
Q2 | $807 | Buy |
1,000
+900
| +900% | +$726 | ﹤0.01% | 3023 |
|
|
2024
Q1 | $1.48K | Sell |
100
-98
| -49% | -$1.45K | ﹤0.01% | 2770 |
|
|
2023
Q4 | $2.86K | Hold |
198
| – | – | ﹤0.01% | 2583 |
|
|
2023
Q3 | $2.13K | Hold |
198
| – | – | ﹤0.01% | 2817 |
|
|
2023
Q2 | $2.55K | Sell |
198
-3
| -1% | -$39 | ﹤0.01% | 2796 |
|
|
2023
Q1 | $6.54K | Sell |
201
-1
| -0.5% | -$33 | ﹤0.01% | 2465 |
|
|
2022
Q4 | $8K | Sell |
202
-1
| -0.5% | -$40 | ﹤0.01% | 3550 |
|
|
2022
Q3 | $8K | Hold |
203
| – | – | ﹤0.01% | 3798 |
|
|
2022
Q2 | $8K | Hold |
203
| – | – | ﹤0.01% | 3551 |
|
|
2022
Q1 | $8K | Sell |
203
-3
| -1% | -$118 | ﹤0.01% | 3551 |
|
|
2021
Q4 | $6K | Hold |
206
| – | – | ﹤0.01% | 2386 |
|
|
2021
Q3 | $9K | Sell |
206
-10
| -5% | -$437 | ﹤0.01% | 2277 |
|
|
2021
Q2 | $8K | Buy |
216
+31
| +17% | +$1.15K | ﹤0.01% | 2294 |
|
|
2021
Q1 | $6K | Buy |
185
+65
| +54% | +$2.11K | ﹤0.01% | 2344 |
|
|
2020
Q4 | $4K | Buy |
120
+10
| +9% | +$333 | ﹤0.01% | 2412 |
|
|
2020
Q3 | $2K | Hold |
110
| – | – | ﹤0.01% | 2487 |
|
|
2020
Q2 | $2K | Hold |
110
| – | – | ﹤0.01% | 2400 |
|
|
2020
Q1 | $2K | Buy |
+110
| New | +$2K | ﹤0.01% | 2361 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | -$1K | – | 3460 |
|
|
2019
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 2903 |
|
|
2019
Q1 | – | Sell |
-50
| Closed | -$1K | – | 3185 |
|
|
2018
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 3318 |
|